> Home     > Preclinical Studies     > Clinical Program     > QC Technology     > Corporate Overview     > Newsroom
 
 
 
» Preclinical Studies Home
---------------------------
» PHY906
      Colorectal Cancer
      Liver Cancer
      Pancreatic Cancer
      Scientific Abstracts
» PHY626, PHY808, PHY777
------------------------------
» Traditional Chinese Medicine
------------------------------
 
 
 
 
 
 
 
PHY906 Preclinical Scientific Abstracts
 

*

“A Phase I/II, Multi-center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 plus Capecitabine in Patients with Advanced Pancreatic Carcinoma”
    Muhammad Wasif Saif, Lynne Lamb, Nichole Grant, Maria Mezes, Shwu Huey Liu, Zaoli Jiang, Yung-Chi Cheng
    (Submitted to clinical CRC journal 2007)
 
* “PHY906 in Hepatocellular Carcinoma”
Shwu-Huey Liu, Zaoli Jiang, Angeline Foo, Wing Lam, Min Ye, Yashang Lee, Duncan Liang, Susan Grill, Yun Yen, Michal Rose, Samuel So, Wasif Saif, Edward Chu, Robert Tilton and Yung-Chi Cheng
Proc. Am Assoc Cancer Res. 2007: #1841
 
* “Phase I/II Study of PHY906/Capecitabine in Hepatocellular Carcinoma”
Michal Rose, Yun Yen, Samuel So, M.W. Saif, Edward Chu, Shwu-Huey Liu, Zaoli Jiang, Angeline Foo, Robert Tilton and Yung-Chi Cheng
Accepted by 2007 ASCO annual meeting)
 
* “Synergistic Activity of PHY906 with Capecitabine in Pancreatic Carcinoma”
M. W. Saif, S. Liu, A. Elfiky, Z. Jiang, Y. Cheng
Accepted by 2007 ASCO annual meeting
 
* "PHY906 as a Broad-Spectrum Enhancer in Cancer Therapy: Clinical and Preclinical Results in Hepatocellular Carcinoma"
Shwu-Huey Liu, Angeline Foo, Zaoli Jiang, Rajendra Marathe, Jing Guan, Tah-Mun Su, Robert Tilton, Yun Yen, Michal Rose, Samuel So, Edward Chu and Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2006: #2145
 
* "Dipropyloxy baicalein, a biochemical modulator in facilitating the oral uptake of drugs"
Shwu-Huey Liu, Yashang Lee, Zaoli Jiang, Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2006: #2142
 
* "Polychemical Botanicals: The Future Of Medicine"
Shwu-Huey Liu, Zaoli Jiang, Angeline Foo, Rajendra Marathe, Jing Guan, Tah-Mun Su, Robert Tilton, and Yung-Chi Cheng
Proceedings of the 11th SCBA International Symposium 2006
 
* “Preclinical Studies of PHY906 in Cancer Chemotherapy”
Shwu-Huey Liu, Zaoli Jiang, Wing Lam, Min Ye, Yashang Lee, Duncan Liang, Susan Grill, Robert Tilton, and Yung-Chi Cheng
Proceedings of the Fifth Meeting of Consortium for Globalization of Chinese Medicine2006
 
  “PHY906 in Advanced Colorectal and Hepatocellular Cancer Clinical Trials”
Edward Chu, Yun Yen, Michal Rose, Samuel So, Shivanni Kumar, Wasif Saif, James J. Lee, Scott Wadler, Mark O’Rouke, Leslie R. Laufman, Shwu-Huey Liu and Yung-Chi Cheng
Proceedings of the Fifth Meeting of Consortium for Globalization of Chinese Medicine 2006
 
  “Progress Towards a High Quality Metric for Botanical Quality Control”
Jing Guan, Zaoli Jiang, Shwu-Huey Liu, Rajendra Marathe, Winfried van Eyndhoven, Hailong Wang, Robert Tilton, Yung-Chi Cheng
Proceedings of the Fifth Meeting of Consortium for Globalization of Chinese Medicine 2006
 
“Seeking FDA Approval for a Botanical Prescription Drug: Case Study of PHY906”

Shwu-Huey Liu, Zaoli Jiang, Tah-Mun Su, Robert Tilton, Edward Chu and Yung-Chi Cheng
Proceeding of “ 20th Natural Medicine Conference (2005)

 
“PHY906: Enhancement of Cancer Chemotherapeutic Agents and Insights into Mechanism of Action”

Shwu-Huey Liu, Zaoli Jiang, Duncan Leung, Yashang Lee and Yung-Chi Cheng
Proceedings of “Medicine in the 21st Century Tri-Conference and Bio-Forum 2004, ” p. 77 (2004)

 

“Developing PHY906 as a Broad- Spectrum Modulator of Chemotherapeutic Agents in Cancer Therapy”

Shwu-Huey Liu, Zaoli Jiang, Tah-Mun Su, Wen-Yi Gao, Chung-Hang Leung, Yashang Lee and Yung-Chi Cheng
Proc. Am Assoc Cancer Res. 2004; 45:128, #557

Poster

 
“PHY906, a Chinese herbal formulation enhances the therapeutic effect of cancer chemotherapy in human colorectal and liver cancer”

Shwu-Huey Liu, Zaoli Jiang, Wenli Gao, Yashang Lee, Ginger Dutschman Tahmun Su, Jay Xu, Robert Tilton, Shivaani Kummar, and Yung-Chi Cheng.

Proc. Am Soc Clin Oncol. 2003, #864.

 
  “Scutellaria baicalensis Georgi, a commonly used herb in Chinese medicine, could facilitate oral absorption of drugs and overcome multidrug resistance in cancer caused by P-glycoprotein 170”

Yashang Lee, Shwu-Huey Liu, Zaoli Jiang and Yung-Chi Cheng

Proc. Am Assoc Cancer Res. 2003; 44:862, #3767

 
“Developing PHY906 as a modulator in cancer chemotherapy”

Shwu-Huey Liu
Proceedings of 3rd TWGHS-CUHK Eddie Wang Symposium on Complementary Chinese and Western Medicine Integrated Approach. p. 69 (2002)

 
“Botanical Activity Relationship in Traditional Chinese Medicine: Studies of PHY906 as an Adjuvant Therapy with Cancer Chemotherapeutic Agents”

Shwu-Huey Liu, Zaoli Jiang and Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2002; 43:961, #4758.

Poster

 
“A Chinese Medicine Formulation, PHY-906, Can Enhance The Therapeutic Index of CPT-11 and Other Anticancer Drugs Against Cancer in Mice”

Liu, Shwu-Huey; Jiang, Zaoli; Cheng, Yung-Chi
Proc. Am Assoc Cancer Res. 2001; 42:85, 458.

Poster

 
“Using Modern Technology in Developing a Chinese Herbal Medicine”

Shwu-Huey Liu, Zaoli Jiang, Jim Liddil, Elizabeth A. Gullen and Yung-Chi Cheng.
Proceedings of The Third Symposium on Herbal Medicine: Taking Herbal Medicine into the Global Mainstream Healthcare System in the 21th Century. P. 39 (2000)

 
“Prevention of CPT-11 Induced Toxicity by a Chinese Medicinal Formulation, PHY-906”

Shwu-Huey Liu, Z. Jiang, J Liddil, K. Hu, E. A. Gullen and Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2000; 41:410, 2608.

Poster

 
 
 
 

PhytoCeutica, Inc. 5 Science Park, Suite 13,New Haven, CT  06511, Phone: 203-777-3462, Fax: 203-777-3538

E-mail: info@phytoceutica.com

www.audinwebdesign.com